9 october, 2009 20:14
"The tasks that the state and the pharmaceutical companies face are clear. First, the policy for the state to purchase medicines needs to be overhauled to introduce clear-cut, transparent market rules to eliminate the possibility of loopholes and abuses, which allow sidestepping the terms of a public auction. When public auctions are aboveboard, prices fall significantly."
